Bosulif 100 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FV703
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,023
Award facts
- Contract value 100% obligated
- $12,023.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,023.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of BOSULIF 100 mg tablets (120 count) on January 21, 2026, with completion scheduled for February 11, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, supplies an extensive portfolio of medications and medical commodities across multiple therapeutic domains to military and veteran healthcare systems. The BOSULIF (bosutinib) medication being procured under this order is an oncology therapeutic used in cancer treatment, consistent with the company's demonstrated capability to deliver specialized pharmaceutical products supporting the Defense Health Agency and other federal healthcare systems. The competitively awarded delivery order reflects the contractor's ongoing role in fulfilling essential pharmaceutical supply needs for the Department of Defense medical infrastructure.
Quick answers
Who was awarded contract SPE2DR26FV703?
SPE2DR26FV703 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV703 worth?
The government has obligated $12,023 on SPE2DR26FV703.
Is contract SPE2DR26FV703 an order under another contract?
Yes. SPE2DR26FV703 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV703 competed?
The extent of competition for SPE2DR26FV703 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award